The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
A specific miRNA signature in the peripheral blood of glioblastoma patients
Open accessAbstract
J. Neurochem. (2011) 118, 449–457. The prognosis of patients afflicted by glioblastoma remains poor. Biomarkers for the disease would be desirable in order to allow for an early detection of tumor progression or to indicate rapidly growing tumor subtypes requiring more intensive therapy. In this study, we investigated whether a blood‐derived specific miRNA fingerprint can be defined in patients with glioblastoma. To this end, miRNA profiles from the blood of 20 patients with glioblastoma and 20 age‐ and sex‐matched healthy controls were compared. Of 1158 tested miRNAs, 52 were significantly deregulated, as assessed by unadjusted Student′s t‐test at an alpha level of 0.05. Of these, two candidates, miR‐128 (up‐regulated) and miR‐342‐3p (down‐regulated), remained significant after correcting for multiple testing by Benjamini–Hochberg adjustment with a p‐value of 0.025. The altered expression of these two biomarkers was confirmed in a second cohort of glioblastoma patients and healthy controls by real‐time PCR and validated for patients who had received neither radio‐ nor chemotherapy and for patients who had their glioblastomas resected more than 6 months ago. Moreover, using machine learning, a comprehensive miRNA signature was obtained that allowed for the discrimination between blood samples of glioblastoma patients and healthy controls with an accuracy of 81% [95% confidence interval (CI) 78–84%], specificity of 79% (95% CI 75–83%) and sensitivity of 83% (95% CI 71–85%). In summary, our proof‐of‐concept study demonstrates that blood‐derived glioblastoma‐associated characteristic miRNA fingerprints may be suitable biomarkers and warrant further exploration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Self-citationExtensive modulation of a set of microRNAs in primary glioblastoma
Ciafrè, S. A., Galardi, S., Mangiola, A., Ferracin, M., Liu, C.-G., Sabatino, G., Negrini, M., Maira, G., Croce, C. M., & Farace, M. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.030 · Cited by 1,096
Hu, Z., Chen, X., Zhao, Y., Tian, T., Jin, G., Shu, Y., Chen, Y., Xu, L., Zen, K., Zhang, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.9342 · Cited by 798
Malzkorn, B., Wolter, M., Liesenberg, F., Grzendowski, M., Stühler, K., Meyer, H. E., & Reifenberger, G. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00328.x · Cited by 352
Cited by
Goodenberger, M. L., & Jenkins, R. B. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.10.009 · Cited by 846
Tumor-Derived Exosomes and Their Role in Cancer Progression
(2016) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2015.12.005 · Cited by 755
Circulating miRNA Biomarkers for Alzheimer's Disease
Kumar, P., Dezso, Z., MacKenzie, C., Oestreicher, J., Agoulnik, S., Byrne, M., Bernier, F., Yanagimachi, M., Aoshima, K., & Oda, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069807 · Cited by 381
Toward the blood-borne miRNome of human diseases
Keller, A., Leidinger, P., Bauer, A., ElSharawy, A., Haas, J., Backes, C., Wendschlag, A., Giese, N., Tjaden, C., Ott, K., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1682 · Cited by 355
Self-citationA small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool
Manterola, L., Guruceaga, E., Pérez-Larraya, J. G., González-Huarriz, M., Jauregui, P., Tejada, S., Diez-Valle, R., Segura, V., Samprón, N., Barrena, C., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not218 · Cited by 345
Metadata
- Authors
- Roth, P., Wischhusen, J., Happold, C., Chandran, P. A., Hofer, S., Eisele, G., Weller, M., & Keller, A.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2011-06-17
- Volume
- 118
- Issue
- 3
- Pages
- 449-457
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1495644609
- Cited by
- 200
- References
- 4
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A specific miRNA signature in the peripheral blood of glioblastoma patients. https://app.cochat.ai/papers/10.1111/j.1471-4159.2011.07307.x
- The paper
- Roth, P., Wischhusen, J., Happold, C., Chandran, P. A., Hofer, S., Eisele, G., Weller, M., & Keller, A. (2011). A specific miRNA signature in the peripheral blood of glioblastoma patients. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2011.07307.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.